FDA is issuing this guidance to provide recommendations to health care providers and investigators on the administration and study of investigational convalescent plasma collected from individuals who have recovered from COVID-19 (COVID-19 convalescent plasma) during the public health emergency.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JRD7fD
No comments:
Post a Comment